Notice about cookies

Close

This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy. By clicking Accept below or continuing to use this website (including closing this message), you confirm that you have read and consent to our use of cookies as detailed in our Cookie Policy.

Accept

UCB's Global Corporate Website
Welcome to UCB in the United States

Newsroom

Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results

 

 

UCB U.S. News

Apr 12, 2024

UCB presents new data highlighting developments across expansive neurology portfolio at 76th…

Read More
Apr 11, 2024

Our Leadership and Legacy in Epilepsy and Rare Syndromes

Read More
Apr 10, 2024

Striving to Make HStory: UCB’s Mission to Raise Awareness for Hidradenitis Suppurativa

Read More

Twitter Feed

For More Information

Media Contact

Speaker Requests

  

Connect with Us on Social

@UCBUSA Twitter
UCB LinkedIn
UCB Facebook
UCB USA YouTube

© 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
USPR-CORP-0115-00003(2)